Loading Assets...

Emergent's mission is simple — to protect and enhance life.


Learn More

Conference Objective

Emergent BioSolutions is looking both for potential partners for our internal programs, as well as potential collaborations on new programs within our Biodefense and Biosciences divisions.

Emergent BioSolutions Inc.

Main Contact

Ashley Wozniak
Corporate Development

Company Overview

Emergent BioSolutions Inc. (NYSE: EBS) is a global specialty biopharmaceutical company dedicated to one simple mission — to protect and enhance life.

Emergent BioSolutions develops, manufactures, and delivers a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. Emergent BioSolutions also develops and commercializes therapeutics and other specialty products for hospitals and clinics in the areas of hematology/oncology, transplantation, infectious diseases and autoimmune disorders. Through its work, Emergent BioSolutions envisions touching 50 million lives with our products by the year 2025.

  • LSAM
  • Manitoba Government
  • WED